USPTO trademark

EYLEA (AFLIBERCEPT) INJECTION 4U

RegisteredUSPTOWord and designClass 44

"EYLEA (AFLIBERCEPT) INJECTION 4U" is a word and design mark owned by Regeneron Pharmaceuticals, Inc., filed at the USPTO on June 10, 2013. It is registered and covers class 44 (Medical, Beauty, and Agricultural).

View Regeneron Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
EYLEA (AFLIBERCEPT) INJECTION 4U trademark as filed
As filed with the USPTO
Status
Registered
Since September 11, 2024
Filed
June 10, 2013
Registered
July 15, 2014
Expires
Not recorded
Application no.
85955455
Registration no.
4566649
Office
USPTO
United States Patent and Trademark Office
Mark type
Word and design
1 class
Ownership

Who owns EYLEA (AFLIBERCEPT) INJECTION 4U

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Regeneron Pharmaceuticals, Inc.

REGN · Tarrytown, United States

1,200 trademarks in the portfolioView company

Representative

Terrence J. McAllister

Ruggiero McAllister & McMahon LLC

Goods and services

What the mark covers

The products and services EYLEA (AFLIBERCEPT) INJECTION 4U is filed for, grouped by Nice class.

  • providing medical information and treatment support programs in the nature of medical information via the telephone and the internet for professionals, patients, consumers, and the general public regarding pharmaceutical products and services

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Attorney/dom.rep.revoked and/or appointed
  3. Teas revoke/app/change addr of atty/dom rep received
  4. Applicant/correspondence changes (non-responsive) entered
  5. Teas change of owner address received
  6. Notice of acceptance of sec. 8 & 9 - e-mailed
  7. Registered and renewed (first renewal - 10 yrs)
  8. Registered - sec. 8 (10-yr) accepted/sec. 9 granted
  9. Case assigned to post registration paralegal
  10. Teas section 8 & 9 received

10 earlier steps on the official record.

Disputes

Oppositions and cancellations

Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.

FAQ

About EYLEA (AFLIBERCEPT) INJECTION 4U

Who owns the trademark "EYLEA (AFLIBERCEPT) INJECTION 4U"?

The USPTO trademark "EYLEA (AFLIBERCEPT) INJECTION 4U" (application 85955455) is owned by Regeneron Pharmaceuticals, Inc.

What is the status of "EYLEA (AFLIBERCEPT) INJECTION 4U"?

Its status at the USPTO is: registered.

When was "EYLEA (AFLIBERCEPT) INJECTION 4U" registered?

It was registered on July 15, 2014.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull EYLEA (AFLIBERCEPT) INJECTION 4U and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2d7d-b988-71bf-8d38-7b01063ba34a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2d7d-b988-71bf-8d38-7b01063ba34a",
  "object": "trademark",
  "mark_text": "EYLEA (AFLIBERCEPT) INJECTION 4U",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "85955455",
  "filing_date": "2013-06-10",
  "nice_classes": [
    44
  ],
  "owners": [
    {
      "name": "Regeneron Pharmaceuticals, Inc.",
      "entity_id": "ent_019eb7b9-61c0-72de-8690-898c0d1d9b4f"
    }
  ]
}